• 32:33 NovelTrialDesigns-5-6-22-v3.mp4
  • 18:38 Nuts and Bolts of Developing an Investigator-Initiated Trial - Vinay Puduvalli.mp4
  • 04:21 OMRT-6 - Veronica Rendo.mp4

    OMRT-6 - Veronica Rendo.mp4

    OMRT-6 Optimizing MDM2 inhibition for the treatment of high-grade glioma Contact Presenter Veronica Rendo1, Leslie Lupien1, Nicholas Khuu1, Kristine Pelton1, Sophie Lu1, Prasidda Khadka1, Jaldeep Langhnoja2, Timothy Phoenix2, Keith Ligon1, Pratiti Bandopadhayay1, Rameen Beroukhim1 1Dana-Farber...

  • 04:55 OMRT-7 - Sunada Khadka.mp4

    OMRT-7 - Sunada Khadka.mp4

    OMRT-7 Angiogenesis inhibitors strongly synergize with therapeutics targeting tumor metabolism Contact Presenter Sunada Khadka UT MD Anderson Cancer Center, Houston, TX, USA. MD Anderson UT Health GSBS, Houston, TX, USA Angiogenesis inhibition has become a mainstay of oncology despite having ...

  • 02:32:21 Opening, Keynote, Session 1
  • 05:22 OTEH-10 - Tathiane Malta.mp4

    OTEH-10 - Tathiane Malta.mp4

    OTEH-10 Evolutionary trajectory of epigenomic of gliomas Contact Presenter Tathiane Malta1, Thais Sabedot2, Indrani Datta3,4, Frederick Varn5, AnaValeria Castro2, Luciano Garofano6, GLASS Consortium2, Roel Verhaak5, Antonio Iavarone6, Laila Poisson2,3, Houtan Noushmehr2 1School of Pharmaceutic...

  • 04:50 OTEH-12 - Artem Berezovsky.m4v

    OTEH-12 - Artem Berezovsky.m4v

    OTEH-12 Assessing Adaptive Responses to Loss of Extrachromosomal DNA Amplification Contact Presenter Artem Berezovsky1,2, Indrani Datta1, Ruicong She1, Laura Hasselbach1, Laila Poisson1, Ana C. deCarvalho1,2 1Henry Ford Health System, Detroit, Michigan, USA. 2Wayne State University, Detroit, M...

  • 05:48 OTHR-02 - Khalid Shah.mp4

    OTHR-02 - Khalid Shah.mp4

    Engineered “of the shelf” allogeneic cellular therapies for metastatic brain tumors Contact Presenter Khalid Shah, Yohei Kitamura, Wanlu Du, Nobu Kanaya BWH, Harvard Medical School, Boston, MA, USA Brain metastatic patients have multiple metastatic lesions or diagnostically challenging asympt...

  • 04:30 OTHR-03 - Dror Limon.mp4

    OTHR-03 - Dror Limon.mp4

    Brain Metastasis Among Ovarian Cancer Patients Contact Presenter Dror Limon, Eliya Shachar, Lyri Adar, Shira Peleg Hasson, Tamar Safra Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel Background: Brain metastasis (BM) are uncommon among ovarian cancer (OC) patients. Their frequency, risk fa...

  • 05:12 OTHR-06 - Benjamin Jang.mp4

    OTHR-06 - Benjamin Jang.mp4

    PACS Lesion Tracking Tool provides real time automatic information on brain tumor metastasis growth curves and RECIST criteria Benjamin Jang, MingDe Lin, Randy Owens, Khaled Bousabarah, Amit Mahajan, Sandra Abi Fadel, Ichiro Ikuta, Irena Tocino, Mariam Aboian Yale School of Medicine, Connecticu...

  • 05:06 OTHR-10 - Laura Noteware.mp4

    OTHR-10 - Laura Noteware.mp4

    Diverse survival outcomes of HER2+ Breast Cancer Brain Metastases (BrCBM) presenting with isolated brain relapse compared to those with concurrent extracranial disease Contact Presenter Laura Noteware1, Luis Ramirez2, Laura Alder3, Nicole Dalal1, James E. Herndon II2,4, Scott R. Floyd3,5, Am...

  • 04:40 OTHR-11 - Marina Kazarian.mp4

    OTHR-11 - Marina Kazarian.mp4

    Comprehensive Analysis of Driver Mutation Profile in a Cohort of Lung Cancer Patients Using Targeted Gene Panel Analysis with Focus on Brain Metastatic Disease Contact Presenter Marina Kazarian, Jin Cui, Irena Tocino, Amit Mahajan, Mariam Aboian Yale University, New Haven, CT, USA Purpose: Ap...